IL17A and cancer: To elucidate the possible mechanism by which HTD prevents inflammation, a systematic analysis based on pathway enrichment was performed, and our data implicated IL-17 signaling in the anti-inflammatory effects of HTD, which is associated with immunopathology, autoimmune disease, and cancer progression [27].